Effect of Vergence Exercises for Patients With Convergence Insufficiency After Concussion.
NCT ID: NCT05012384
Last Updated: 2023-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2021-07-01
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These patients often have difficulties coordinating the movement of the two eyes (convergence insufficiency) which is essential for single and clear vision to be obtained and is hence a likely explanation for the symptoms.
100 patients with long-term symptoms of concussion and convergence insufficiency will be offered either exercises or placebo treatment the evaluate the effect of exercises aimed at improving coordination between the two eyes.
The study will provide data to support clinicians in deciding whether to use exercises or not as a treatment of symptoms for patients with convergence insufficiency as a long-term consequence of concussion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Persistent Post-Concussion Symptoms With Convergence Insufficiency
NCT05262361
Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI
NCT06848673
The Effectiveness of Visual Training in Convergence Insufficiency Patients
NCT05603962
Spectacles Lens in Concussed Kids
NCT03123822
Study of Oculomotor Dysfunction Leading to Children Vertigo
NCT01153789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vergence exercises
Orthoptic vergence exercises
Vergence exercises (Orthoptic exercises)
Vergence exercises as described by the Convergence Insufficiency Treatment Trials Group (CITT)
Generic treatment
Placebo
Generic management plan with non-visual elements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vergence exercises (Orthoptic exercises)
Vergence exercises as described by the Convergence Insufficiency Treatment Trials Group (CITT)
Placebo
Generic management plan with non-visual elements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Convergence insufficiency which has not been diagnosed prior to the concussion
Exclusion Criteria
* Manifest or paralytic strabismus
* Self-reported eye disease
30 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danish College of Optometry and Vision Science
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danish College of Optometry and Vision Science
Randers, Central Region, Denmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-22-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.